Peter K. Shagory's most recent trade in Conmed Corp. was a trade of 4,500 SARs (Stock Appreciation Rights) done . Disclosure was reported to the exchange on March 14, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Conmed Corp. | Peter K. Shagory | EVP, STRAT & CORP DEVT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Mar 2025 | 4,500 | 0 | - | - | SARs (Stock Appreciation Rights) | |
Conmed Corp. | Peter K. Shagory | EVP, STRAT & CORP DEVT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 55.42 per share. | 14 Mar 2025 | 4,500 | 8,212 (0%) | 0% | 55.4 | 249,390 | Common Stock |
Conmed Corp. | Peter K. Shagory | EVP, STRAT & CORP DEVT | Payment of exercise price or tax liability using portion of securities received from the company at price $ 58.83 per share. | 14 Mar 2025 | 4,316 | 3,896 (0%) | 0% | 58.8 | 253,910 | Common Stock |
Conmed Corp. | Peter K. Shagory | EVP, STRAT & CORP DEVT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 26,127 | 26,127 | - | - | Options To Purchase Common Stock | |
Conmed Corp. | Peter K. Shagory | EVP, STRAT & CORP DEVT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 18,988 | 18,988 | - | - | Options To Purchase Common Stock | |
Conmed Corp. | Peter Shagory K. | EVP, STRAT & CORP DEVT | 31 Dec 2023 | 1 | 3,712 (0%) | 0% | 167 | 167 | Common Stock | |
Conmed Corp. | Peter K. Shagory | EVP, STRAT & CORP DEVT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jun 2023 | 4,500 | 4,500 | - | - | Sars (Stock Appreciation Rights) | |
Conmed Corp. | Peter K. Shagory | EVP, STRAT & CORP DEVT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 55.42 per share. | 09 Jun 2023 | 4,500 | 6,361 (0%) | 0% | 55.4 | 249,390 | Common Stock |
Conmed Corp. | Peter K. Shagory | EVP, STRAT & CORP DEVT | Payment of exercise price or tax liability using portion of securities received from the company at price $ 132.44 per share. | 09 Jun 2023 | 2,650 | 3,711 (0%) | 0% | 132.4 | 350,966 | Common Stock |
Conmed Corp. | Peter K. Shagory | EVP, STRAT & CORP DEVT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 39.87 per share. | 28 Apr 2023 | 2,442 | 4,303 (0%) | 0% | 39.9 | 97,363 | Common Stock |
Conmed Corp. | Peter K. Shagory | EVP, STRAT & CORP DEVT | Sale of securities on an exchange or to another person at price $ 128.00 per share. | 28 Apr 2023 | 2,442 | 1,861 (0%) | 0% | 128 | 312,576 | Common Stock |
Conmed Corp. | Peter K. Shagory | EVP, STRAT & CORP DEVT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Apr 2023 | 2,442 | 0 | - | - | Options To Purchase Common Stock | |
Conmed Corp. | Peter K. Shagory | EVP, STRAT & CORP DEVT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 15,159 | 15,159 | - | - | Options To Purchase Common Stock | |
Conmed Corp. | Peter K. Shagory | EVP, STRAT & CORP DEVT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 20,000 | 20,000 | - | - | Options To Purchase Common Stock | |
Conmed Corp. | Peter K. Shagory | EVP, STRAT & CORP DEVT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 19,550 | 19,550 | - | - | Options To Purchase Common Stock | |
Conmed Corp. | Peter K. Shagory | EVP, STRAT & CORP DEVT | Other type of transaction at price $ 0.00 per share. | 30 Oct 2020 | 11,960 | 14,040 | - | - | Options To Purchase Common Stock | |
Conmed Corp. | Peter K. Shagory | EVP, STRAT & CORP DEVT | Other type of transaction at price $ 0.00 per share. | 30 Oct 2020 | 11,000 | 9,000 | - | - | Sars (Stock Appreciation Rights) | |
Conmed Corp. | Peter K. Shagory | EVP, STRAT & CORP DEVT | Other type of transaction at price $ 0.00 per share. | 30 Oct 2020 | 9,840 | 14,160 | - | - | Options To Purchase Common Stock | |
Conmed Corp. | Peter K. Shagory | EVP, STRAT & CORP DEVT | Other type of transaction at price $ 0.00 per share. | 30 Oct 2020 | 8,865 | 9,435 | - | - | Options To Purchase Common Stock | |
Conmed Corp. | Peter K. Shagory | EVP, STRAT & CORP DEVT | Other type of transaction at price $ 0.00 per share. | 30 Oct 2020 | 8,050 | 14,950 | - | - | Options To Purchase Common Stock | |
Conmed Corp. | Peter K. Shagory | EVP, STRAT & CORP DEVT | Other type of transaction at price $ 0.00 per share. | 30 Oct 2020 | 1,998 | 2,442 | - | - | Options To Purchase Common Stock | |
Conmed Corp. | Peter K. Shagory | EVP, STRAT & CORP DEVT | Sale of securities on an exchange or to another person at price $ 85.88 per share. | 04 Sep 2020 | 4,200 | 1,861 (0%) | 0% | 85.9 | 360,696 | Common Stock |
Conmed Corp. | Peter K. Shagory | EVP, STRAT & CORP DEVT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Sep 2020 | 4,200 | 18,300 | - | - | Options To Purchase Common Stock | |
Conmed Corp. | Peter K. Shagory | EVP, STRAT & CORP DEVT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 41.93 per share. | 04 Sep 2020 | 4,200 | 6,061 (0%) | 0% | 41.9 | 176,106 | Common Stock |